Cardiovascular actions of angiotensin-(1-7)

Albiston AL, 2001, Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase, Journal of Biological Chemistry, 276, 48623, 10.1074/jbc.C100512200

Tipnis SR, 2000, A human homolog of angiotensin-converting enzyme: Cloning and functional expression as a captopril-insensitive carboxypeptidase, Journal of Biological Chemistry, 275, 33238, 10.1074/jbc.M002615200

Donoghue M, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9, Circulation Research, 87, E1, 10.1161/01.RES.87.5.e1

Nguyen G, 1996, Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen, Kidney International, 50, 1897, 10.1038/ki.1996.511

Santos RAS, 2003, Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas, Proceedings of the National Academy of Sciences, USA, 100, 8258, 10.1073/pnas.1432869100

Wen Q, 2004, Reduction of infarct size by orally administered des-aspartate-angiotensin I in the ischemic reperfused rat heart, Regulatory Peptides, 120, 149, 10.1016/j.regpep.2004.03.003

Santos RAS, 2000, Angiotensin-(1-7): an update, Regulatory Peptides, 91, 45, 10.1016/S0167-0115(00)00138-5

Schmaier AH, 2003, The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction, American Journal of Physiology, 285, R1

Carey RM, 2003, Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation, Endocrine Reviews, 24, 261, 10.1210/er.2003-0001

Burrell LM, 2004, ACE2, a new regulator of the renin-angiotensin system, Trends in Endocrinology and Metabolism, 15, 166, 10.1016/j.tem.2004.03.001

Ferrario CM, 2002, Does angiotensin-(1-7) contribute to cardiac adaptation and preservation of endothelial function in heart failure?, Circulation, 105, 1523, 10.1161/01.CIR.0000013787.10609.DC

Campbell DJ, 2003, The renin-angiotensin and the kallikrein-kinin systems, International Journal of Biochemistry and Cell Biology, 35, 784, 10.1016/S1357-2725(02)00262-5

Roks AJ, 1999, Angiotensin-(1-7) is a modulator of the human renin-angiotensin system, Hypertension, 34, 296, 10.1161/01.HYP.34.2.296

Pinheiro SVB, 2004, Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney, Hypertension, 44, 490, 10.1161/01.HYP.0000141438.64887.42

Brosnihan KB, 1996, Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide, Hypertension, 27, 523, 10.1161/01.HYP.27.3.523

Ferreira AJ, 2001, Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion, Hypertension, 38, 665, 10.1161/01.HYP.38.3.665

Loot AE, 2002, Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats, Circulation, 105, 1548, 10.1161/01.CIR.0000013847.07035.B9

Santos RAS, 1990, The renin-angiotensin system during acute myocardial ischemia in dogs, Hypertension, 15, I

Neves LA, 1995, Metabolism of angiotensin I in isolated rat hearts: Effect of angiotensin converting enzyme inhibitors, Biochemical Pharmacology, 50, 1451, 10.1016/0006-2952(95)02049-7

Mahmood A, 2002, Metabolism of angiotensin I in the coronary circulation of normal and diabetic rats, Peptides, 23, 1171, 10.1016/S0196-9781(02)00051-7

Zisman LS, 2003, Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate, Circulation, 108, 1679, 10.1161/01.CIR.0000094733.61689.D4

Vickers C, 2002, Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase, Journal of Biological Chemistry, 277, 14838, 10.1074/jbc.M200581200

Rice GI, 2004, Evaluation of angiotensin converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism, Biochemical Journal, 383, 45, 10.1042/BJ20040634

Crackower MA, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786

Zisman LS, 2003, Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for up regulation of the angiotensin-converting enzyme homologue ACE2, Circulation, 108, 1707, 10.1161/01.CIR.0000094734.67990.99

Goulter AB, 2004, ACE2 gene expression is up-regulated in the human failing heart, BMC Medicine, 2, 19, 10.1186/1741-7015-2-19

Averill DB, 2003, Cardiac angiotensin-(1-7) in ischemic cardiomyopathy, Circulation, 106, 2141, 10.1161/01.CIR.0000092888.63239.54

Neves LAA, 1997, Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts, Brazilian Journal of Medical and Biological Research, 30, 801, 10.1590/S0100-879X1997000600016

Kumagai H, 1990, Biological activity of angiotensin-(1-7) heptapeptide in the hamster heart, Hypertension, 15, I, 10.1161/01.HYP.15.2_Suppl.I29

Almeida AP, 2000, Angiotensin-(1-7) potentiates the coronary vasodilatory effect of bradykinin in the isolated rat heart, Brazilian Journal of Medical and Biological Research, 33, 709, 10.1590/S0100-879X2000000600012

Sampaio WO, 2003, Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats, American Journal of Physiology, 284, H1985

Ferreira AJ, 2002, Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts, Brazilian Journal of Medical and Biological Research, 35, 1083, 10.1590/S0100-879X2002000900009

Donoghue M, 2003, Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins, Journal of Molecular and Cellular Cardiology, 35, 1043, 10.1016/S0022-2828(03)00177-9

Santos RAS, 2004, Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats, Physiological Genomics, 17, 292, 10.1152/physiolgenomics.00227.2003

Santos RAS, 1992, Production of angiotensin-(1-7) by human vascular endothelium, Hypertension, 19, II

Chappell MC, 1998, Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme, Hypertension, 31, 362, 10.1161/01.HYP.31.1.362

Ren Y, 2002, Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles, Hypertension, 39, 799, 10.1161/hy0302.104673

Fernandes L, 2001, Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo, Hypertension, 37, 703, 10.1161/01.HYP.37.2.703

Sasaki S, 2001, Angiotensin-(1-7) induces endothelium-independent vasodilation in normotensive control subjects and essential hypertensive patients, Hypertension, 38, 90, 10.1161/01.HYP.38.1.90

Davie AP, 1999, Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor, Hypertension, 34, 457, 10.1161/01.HYP.34.3.457

Nakamura S, 2003, Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR, American Journal of Physiology, 284, R164

Collister JP, 2003, The role of Ang (1-7) in mediating the chronic hypotensive effects of losartan in normal rats, Journal of the Renin-Angiotensin-Aldosterone System, 4, 176, 10.3317/jraas.2003.028

Heitsch H, 2001, Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells, Hypertension, 37, 72, 10.1161/01.HYP.37.1.72

Muthalif MM, 1998, Signal transduction mechanism involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth cells, Journal of Pharmacology and Experimental Therapeutics, 284, 388

Soares de Moura R, 2004, The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat, British Journal of Pharmacology, 141, 860, 10.1038/sj.bjp.0705669

Min L, 2000, Effects of des-aspartate-angiotensin I on angiotensin II-induced incorporation of phenylalanine and thymidine in cultured rat cardiomyocytes and aortic smooth muscle cells, Regulatory Peptides, 95, 93, 10.1016/S0167-0115(00)00162-2

Tallant EA, 2004, Inhibition of MAP kinase activity by angiotensin-(1-7) in vascular smooth muscle cells is mediated by the Mas receptor, Hypertension, 43, 1348

Paula RD, 1995, Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats, Hypertension, 26, 1154, 10.1161/01.HYP.26.6.1154

Ueda S, 2001, Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man, Journal of Hypertension, 19, 2001, 10.1097/00004872-200111000-00010

Tom B, 2001, Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade, Hypertension, 38, 95, 10.1161/01.HYP.38.1.95

Wilsdorf T, 2001, Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm, Hypertension, 37, 1136, 10.1161/01.HYP.37.4.1136

Erdos EG, 2002, Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin, Journal of Molecular and Cellular Cardiology, 34, 1569, 10.1006/jmcc.2002.2080

Maia LG, 2004, Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats, Journal of Cardiovascular Pharmacology, 43, 685, 10.1097/00005344-200405000-00011

Stegbauer J, 2004, Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats, Cardiovascular Research, 61, 352, 10.1016/j.cardiores.2003.11.017

Metzger R, 1995, Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues, FEBS Letters, 357, 27, 10.1016/0014-5793(94)01292-9

Castro CH, 2004, Effects of genetic deletion of the G-protein-coupled receptor Mas on cardiac function during ischemia and reperfusion in the mouse isolated perfused heart, Hypertension, 43, 1350

Gembardt F, 2003, Deficiency in the G protein-coupled receptor Mas leads to cardiomyopathy and demonstrates the importance of the endogenous ligand angiotensin-(1-7) for the cardiac function, Naunyn-Schmiedebergs Archives of Pharmacology, 369, R68

Walther T, 2000, Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene, Brazilian Journal of Medical and Biological Research, 33, 1, 10.1590/S0100-879X2000000100001

Wiemer G, 2002, AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium, Hypertension, 40, 847, 10.1161/01.HYP.0000037979.53963.8F

Gironacci MM, 1994, Effects of angiotensin II and angiotensin-(1-7) on the release of (³H)norepinephrine from rat atria, Hypertension, 24, 457, 10.1161/01.HYP.24.4.457